Avapritinib's 4-Year PIONEER Data Show Durable QoL Benefits in ISM

Source Summary

Thanai Pongdee, MD, discusses how PIONEER data reveal quality of life gains that go beyond symptom and biomarker control in indolent systemic mastocytosis.